Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $40 | $37 | $33 | $29 |
| - Cash | $5 | $2 | $6 | $3 |
| + Debt | $3 | $3 | $3 | $1 |
| Enterprise Value | $38 | $38 | $30 | $27 |
| Revenue | $16 | $13 | $13 | $10 |
| % Growth | 26.4% | -2% | 30.1% | – |
| Gross Profit | $10 | $9 | $11 | $1 |
| % Margin | 63.2% | 66.2% | 85.4% | 13% |
| EBITDA | -$2 | -$5 | -$2 | -$4 |
| % Margin | -9.4% | -40.1% | -11.7% | -41.3% |
| Net Income | -$4 | -$5 | -$3 | -$6 |
| % Margin | -22.4% | -41.7% | -24% | -55.5% |
| EPS Diluted | -0.014 | -0.024 | -0.015 | -0.029 |
| % Growth | 41.3% | -62.1% | 49.5% | – |
| Operating Cash Flow | -$3 | -$4 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$4 | -$4 | -$4 |